These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38529601)

  • 1. Disruptions of Gut Microbiota are Associated with Cognitive Deficit of Preclinical Alzheimer's Disease: A Cross-Sectional Study.
    Yu B; Wan G; Cheng S; Wen P; Yang X; Li J; Tian H; Gao Y; Zhong Q; Liu J; Li J; Zhu Y
    Curr Alzheimer Res; 2024; 20(12):875-889. PubMed ID: 38529601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
    Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
    Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study.
    Sheng C; Lin L; Lin H; Wang X; Han Y; Liu SL
    J Alzheimers Dis; 2021; 82(2):513-526. PubMed ID: 34024839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.
    Guo M; Peng J; Huang X; Xiao L; Huang F; Zuo Z
    J Alzheimers Dis; 2021; 80(1):299-310. PubMed ID: 33523001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Composition Is Related to AD Pathology.
    Verhaar BJH; Hendriksen HMA; de Leeuw FA; Doorduijn AS; van Leeuwenstijn M; Teunissen CE; Barkhof F; Scheltens P; Kraaij R; van Duijn CM; Nieuwdorp M; Muller M; van der Flier WM
    Front Immunol; 2021; 12():794519. PubMed ID: 35173707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer's disease: a cross-sectional analysis from the SILCODE study.
    Sheng C; Yang K; He B; Du W; Cai Y; Han Y
    Alzheimers Res Ther; 2022 Feb; 14(1):35. PubMed ID: 35164860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer's Disease.
    Zhou Y; Wang Y; Quan M; Zhao H; Jia J
    J Alzheimers Dis; 2021; 81(2):583-595. PubMed ID: 33814442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Gut Microbial Metabolites in Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Signals in Host-Microbe Interplay.
    Wu L; Han Y; Zheng Z; Peng G; Liu P; Yue S; Zhu S; Chen J; Lv H; Shao L; Sheng Y; Wang Y; Li L; Li L; Wang B
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33466861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Gut Microbiota and Its Clinical Relevance in Mild Cognitive Impairment and Alzheimer's Disease: Shanghai Aging Study and Shanghai Memory Study.
    Zhu Z; Ma X; Wu J; Xiao Z; Wu W; Ding S; Zheng L; Liang X; Luo J; Ding D; Zhao Q
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diet quality, gut microbiota, and microRNAs associated with mild cognitive impairment in middle-aged and elderly Chinese population.
    Zhang X; Wang Y; Liu W; Wang T; Wang L; Hao L; Ju M; Xiao R
    Am J Clin Nutr; 2021 Aug; 114(2):429-440. PubMed ID: 33871591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elderly Patients with Mild Cognitive Impairment Exhibit Altered Gut Microbiota Profiles.
    Pan Q; Li YQ; Guo K; Xue M; Gan Y; Wang K; Xu DB; Tu QY
    J Immunol Res; 2021; 2021():5578958. PubMed ID: 34869782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Gut Microbiota with Mild Cognitive Impairment and Alzheimer's Disease in a Thai Population.
    Wanapaisan P; Chuansangeam M; Nopnipa S; Mathuranyanon R; Nonthabenjawan N; Ngamsombat C; Thientunyakit T; Muangpaisan W
    Neurodegener Dis; 2022; 22(2):43-54. PubMed ID: 36070704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiome composition may be an indicator of preclinical Alzheimer's disease.
    Ferreiro AL; Choi J; Ryou J; Newcomer EP; Thompson R; Bollinger RM; Hall-Moore C; Ndao IM; Sax L; Benzinger TLS; Stark SL; Holtzman DM; Fagan AM; Schindler SE; Cruchaga C; Butt OH; Morris JC; Tarr PI; Ances BM; Dantas G
    Sci Transl Med; 2023 Jun; 15(700):eabo2984. PubMed ID: 37315112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free water in gray matter linked to gut microbiota changes with decreased butyrate producers in Alzheimer's disease and mild cognitive impairment.
    Yamashiro K; Takabayashi K; Kamagata K; Nishimoto Y; Togashi Y; Yamauchi Y; Ogaki K; Li Y; Hatano T; Motoi Y; Suzuki M; Miyakawa K; Ishikawa D; Aoki S; Urabe T; Hattori N
    Neurobiol Dis; 2024 Apr; 193():106464. PubMed ID: 38452948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota in patients with Alzheimer's disease spectrum: a systematic review and meta-analysis.
    Hung CC; Chang CC; Huang CW; Nouchi R; Cheng CH
    Aging (Albany NY); 2022 Jan; 14(1):477-496. PubMed ID: 35027502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of
    Ueda A; Shinkai S; Shiroma H; Taniguchi Y; Tsuchida S; Kariya T; Kawahara T; Kobayashi Y; Kohda N; Ushida K; Kitamura A; Yamada T
    Cell Rep Med; 2021 Sep; 2(9):100398. PubMed ID: 34622235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
    Heravi FS; Naseri K; Hu H
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome dysbiosis in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    Jemimah S; Chabib CMM; Hadjileontiadis L; AlShehhi A
    PLoS One; 2023; 18(5):e0285346. PubMed ID: 37224131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning-based classification of Alzheimer's disease and its at-risk states using personality traits, anxiety, and depression.
    Waschkies KF; Soch J; Darna M; Richter A; Altenstein S; Beyle A; Brosseron F; Buchholz F; Butryn M; Dobisch L; Ewers M; Fliessbach K; Gabelin T; Glanz W; Goerss D; Gref D; Janowitz D; Kilimann I; Lohse A; Munk MH; Rauchmann BS; Rostamzadeh A; Roy N; Spruth EJ; Dechent P; Heneka MT; Hetzer S; Ramirez A; Scheffler K; Buerger K; Laske C; Perneczky R; Peters O; Priller J; Schneider A; Spottke A; Teipel S; Düzel E; Jessen F; Wiltfang J; Schott BH; Kizilirmak JM
    Int J Geriatr Psychiatry; 2023 Oct; 38(10):e6007. PubMed ID: 37800601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.